Baidu
map

ESC2015:NSTE-ACS指南诊断和监测要点

2015-09-07 大鹏 译 医学论坛网

2015欧洲心脏病学会年会(ESC2015)专题报道一、诊断及风险分层要点1.新指南推荐,医生应综合患者病史、症状、体征、体格检查其他要点、心电图检查(ECG)及实验室检查结果等多方面信息,作出诊断并评估患者短期缺血及出血分层情况。(推荐等级Ⅰ,证据等级A)2.推荐患者首次医疗接触后10分钟之内接受12导联ECG检查,并邀请有经验的临床医生解读ECG检查结果。另外,若患者再发症状或存在诊断不确定性

2015欧洲心脏病学会年会(ESC2015)专题报道

一、诊断及风险分层要点

1.新指南推荐,医生应综合患者病史、症状、体征、体格检查其他要点、心电图检查(ECG)及实验室检查结果等多方面信息,作出诊断并评估患者短期缺血及出血分层情况。(推荐等级Ⅰ,证据等级A)

2.推荐患者首次医疗接触后10分钟之内接受12导联ECG检查,并邀请有经验的临床医生解读ECG检查结果。另外,若患者再发症状或存在诊断不确定性,推荐复查12导联ECG。(推荐等级Ⅰ,证据等级B)

3.若怀疑患者存在持续缺血,且标准导联ECG结果无法确诊,推荐复查相应导联ECG检查,包括V3R,V4R,V7,V8及V9。(推荐等级Ⅰ,证据等级C)


4.推荐行心肌肌钙蛋白或高敏心肌肌钙蛋白检查,并在60分钟内获得结果。(推荐等级Ⅰ,证据等级A)

5.若患者能接受高敏心肌肌钙蛋白检查,推荐在0小时及3小时两个时间点行快速排除法诊断(rule-out protocol)。(推荐等级Ⅰ,证据等级B)

6.若患者能接受高敏心肌肌钙蛋白检查,且存在有效的0h/1h算法(0 h/1 h algorithm),推荐在0小时及1小时两个时间点行快速排除法诊断及确诊诊断;若前两次检查无法确诊,而患者又高度疑似急性冠脉综合征(ACS),推荐在3至6小时之间复查。(推荐等级Ⅰ,证据等级B)

7.推荐使用已有的评分工具评估患者预后。(推荐等级Ⅰ,证据等级B)

8.对于正接受冠脉造影术的患者,可考虑使用CRUSADE评分定量评估出血风险。(推荐等级Ⅱb,证据等级B)

二、影像学检查要点

1.对于无复发性胸痛的患者,若患者ECG及心肌肌钙蛋白均正常,但疑似ACS,在制定有创性诊疗策略前,推荐进行配有影像的微创应激试验以确定可诱导的缺血情况。(推荐等级Ⅰ,证据等级A)

2.推荐行超声心动图检查评估患者局部及全左心室功能情况,以资鉴别诊断。(推荐等级Ⅰ,证据等级C)

3.若患者存在低中度冠心病可能性,且ECG及心肌肌钙蛋白检查无法确诊,可考虑多排螺旋CT(MDCT)冠脉造影是一种可选的有创性影像学检查,用以ACS排除诊断。(推荐等级Ⅱa,证据等级A)

三、监测要点

1.在患者非ST段抬高型心肌梗死(NSTEMI)诊断结果明确前,推荐行连续心律监测。(推荐等级Ⅰ,证据等级C)

2.推荐将NSTEMI患者移至监测中心治疗。(推荐等级Ⅰ,证据等级C)

3.对于心律失常低危的NSTEMI患者,可考虑心律监测(最长24小时)或PCI治疗。(推荐等级Ⅱa,证据等级C)

4.对于心律失常中高危的NSTEMI患者,可考虑超过24小时的心律监测。(推荐等级Ⅱa,证据等级C)

5.若患者无持续性缺血体征或症状,对于特定患者群体(如疑似冠脉痉挛,存在心律失常相关事件),可考虑在不稳定心绞痛时行心律监测。(推荐等级Ⅱb,证据等级C)


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1947581, encodeId=0a4d194e58155, content=<a href='/topic/show?id=a0291309883' target=_blank style='color:#2F92EE;'>#NSTE-ACS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13098, encryptionId=a0291309883, topicName=NSTE-ACS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Sun Jan 10 23:05:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927969, encodeId=dc8a192e9695d, content=<a href='/topic/show?id=5e1f13101d9' target=_blank style='color:#2F92EE;'>#NSTE-ACS指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13101, encryptionId=5e1f13101d9, topicName=NSTE-ACS指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Wed Jul 13 16:05:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977508, encodeId=c85419e750819, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Dec 10 13:05:00 CST 2015, time=2015-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279106, encodeId=c90f12e910677, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1882, encryptionId=316d1882bc, topicName=ACS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Wed Sep 09 00:05:00 CST 2015, time=2015-09-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1947581, encodeId=0a4d194e58155, content=<a href='/topic/show?id=a0291309883' target=_blank style='color:#2F92EE;'>#NSTE-ACS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13098, encryptionId=a0291309883, topicName=NSTE-ACS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Sun Jan 10 23:05:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927969, encodeId=dc8a192e9695d, content=<a href='/topic/show?id=5e1f13101d9' target=_blank style='color:#2F92EE;'>#NSTE-ACS指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13101, encryptionId=5e1f13101d9, topicName=NSTE-ACS指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Wed Jul 13 16:05:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977508, encodeId=c85419e750819, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Dec 10 13:05:00 CST 2015, time=2015-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279106, encodeId=c90f12e910677, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1882, encryptionId=316d1882bc, topicName=ACS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Wed Sep 09 00:05:00 CST 2015, time=2015-09-09, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1947581, encodeId=0a4d194e58155, content=<a href='/topic/show?id=a0291309883' target=_blank style='color:#2F92EE;'>#NSTE-ACS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13098, encryptionId=a0291309883, topicName=NSTE-ACS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Sun Jan 10 23:05:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927969, encodeId=dc8a192e9695d, content=<a href='/topic/show?id=5e1f13101d9' target=_blank style='color:#2F92EE;'>#NSTE-ACS指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13101, encryptionId=5e1f13101d9, topicName=NSTE-ACS指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Wed Jul 13 16:05:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977508, encodeId=c85419e750819, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Dec 10 13:05:00 CST 2015, time=2015-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279106, encodeId=c90f12e910677, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1882, encryptionId=316d1882bc, topicName=ACS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Wed Sep 09 00:05:00 CST 2015, time=2015-09-09, status=1, ipAttribution=)]
    2015-12-10 drj2003
  4. [GetPortalCommentsPageByObjectIdResponse(id=1947581, encodeId=0a4d194e58155, content=<a href='/topic/show?id=a0291309883' target=_blank style='color:#2F92EE;'>#NSTE-ACS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13098, encryptionId=a0291309883, topicName=NSTE-ACS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=198d2500149, createdName=12498bd5m16暂无昵称, createdTime=Sun Jan 10 23:05:00 CST 2016, time=2016-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1927969, encodeId=dc8a192e9695d, content=<a href='/topic/show?id=5e1f13101d9' target=_blank style='color:#2F92EE;'>#NSTE-ACS指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13101, encryptionId=5e1f13101d9, topicName=NSTE-ACS指南)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30f5146, createdName=zz70, createdTime=Wed Jul 13 16:05:00 CST 2016, time=2016-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977508, encodeId=c85419e750819, content=<a href='/topic/show?id=d9e5130962f' target=_blank style='color:#2F92EE;'>#NST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13096, encryptionId=d9e5130962f, topicName=NST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80c5136, createdName=drj2003, createdTime=Thu Dec 10 13:05:00 CST 2015, time=2015-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1279106, encodeId=c90f12e910677, content=<a href='/topic/show?id=316d1882bc' target=_blank style='color:#2F92EE;'>#ACS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=1882, encryptionId=316d1882bc, topicName=ACS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Wed Sep 09 00:05:00 CST 2015, time=2015-09-09, status=1, ipAttribution=)]
    2015-09-09 yaanren

相关资讯

ACS抗栓治疗:谁是阿司匹林的更佳拍档?

                        2015欧洲心脏病学会年会(ESC2015)专题报道伦敦时间29日下午,一场“治疗ACS,谁是阿司匹林的最佳搭档”的讨论异

吴学思教授:新版心包疾病指南10点新意

2015欧洲心脏病学会年会(ESC2015)专题报道吴学思教授在会场当地时间8月30日上午,ESC新版心包疾病指南在主会场发布,记者邀请北京安贞医院吴学思教授做简要点评。指南工作组两位主席对新版指南作了简明扼要的介绍。ESC上版心包疾病指南发布于2004年,也是此次更新前国际上关于心包疾病唯一被冠以guideline的指导性文件,由于研究证据匮乏,指南未对推荐意见级别作明确界定。10年后的今天,尽

ESC 2015:IMPROVE-IT亚组分析:糖尿病患者胆固醇“低一些更好”

IMPROVE-IT研究是一项具有里程碑意义的临床试验,主要回答了两个备受关注的问题:1.应用非他汀类药物降低胆固醇水平能否获益?2.当LDL-C处于较低水平时继续降低其水平可否进一步获益?该研究结果对上述两个问题均做出了肯定性的回答,从而论证了两个理念:1.降胆固醇是硬道理;2.对于急性冠脉综合征(ACS)患者,胆固醇低一些更好。本届ESC年会期间报道的关于糖尿病患者的亚组分析则发现,联合应用依

全球房颤抗凝治疗现状:GARFIELD-AF研究结果公布及分析

2015欧洲心脏病学会年会(ESC2015)专题报道伦敦时间下午3:30,GARFIELD-AF研究组成员对该研究目前的部分研究结果进行了公布和简要分析。该研究作为目前房颤领域规模最大的全球注册研究,目前已入组45000例患者。初步分析显示,房颤患者诊断后12个月内事件发生率更高。区域分析显示,不同地区新诊断房颤患者的CHA2DS2-VASc评分和HAS-BLED评分不同。与其他患者而相比,亚洲房

ESC2015:心脏骤停应至少接受35分钟专业心肺复苏

2015欧洲心脏病学会年会(ESC2015)专题报道 时间就是生命,对于一个心脏骤停者,到底应该进行多长时间心肺复苏,难道复苏时间越长转归越好?日本金泽大学急诊和重症医学部的Yoshikazu Goto教授在17000余患者中进行的研究表明,那些存活并且神经功能恢复良好的心脏骤停患者,多在接受心肺复苏35分钟内恢复自主循环(图1)。

ESC 2015:血压不易控制或偏低者应当警惕抑郁症

2015欧洲心脏病学会年会(ESC2015)专题报道苏格兰格拉斯哥大学Bhautesh Jani在本届大会上报告的一项最新研究表明,血压很高或较低的人如果同时存在抑郁症状,发生严重心血管事件的风险显著升高,包括心肌梗死、心衰,甚至死亡。研究显示,与无抑郁症且血压正常的人相比,有抑郁症、收缩压又很高的人发生心血管事件的风险增加83%。研究者还意外发现,有抑郁症、收缩压较低的人出现心血管事件的风险也增

Baidu
map
Baidu
map
Baidu
map